Mr. Robert M. Davis, also known as Rob, J.D., has been Chief Financial Officer and Executive Vice President of Global Services at Merck & Co., Inc. since April 23, 2014 and April 2016 respectively. Mr. Davis served as Executive Vice President at Merck & Co., Inc. from April 23, 2014 to April 2016. Mr. Davis served as an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. He has been Director at CR Bard Inc. since October 13, 2015. He served as the President at Renal at Baxter International Inc. from July 5, 2010 to October 2010. He served as the Chief Financial Officer at Baxter International Inc. from May 17, 2006 to July 5, 2010. Mr. Davis served as Treasurer at Baxter International Inc. since November 17, 2004 and also served as its Corporate Vice President. He served at Eli Lilly and Company as Director of Corporate Financial Planning. He joined Eli Lilly in 1990 and served in a number of positions with increasing responsibility in the tax and treasury areas, including Tax Counsel and Assistant Treasurer. Mr. Davis served as an Assistant Treasurer at Eli Lilly. He serves as a Director of Baxter Finco BV and Baxter International Foundation. He served as a Trustee of Rush University Medical Center. He also is a member of the board of directors of AdvaMed. Mr. Davis received his Juries Doctorate, magnum cum laude, from Northwestern University School of Law and his Master's degree in Business Administration from J.L. Kellogg School of Management, Northwestern University and Bachelor's Degree in finance from Miami University.

Finance , medical products, human healthcare